1. Home
  2. JYD vs CING Comparison

JYD vs CING Comparison

Compare JYD & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYD
  • CING
  • Stock Information
  • Founded
  • JYD 2001
  • CING 2012
  • Country
  • JYD China
  • CING United States
  • Employees
  • JYD N/A
  • CING N/A
  • Industry
  • JYD Oil Refining/Marketing
  • CING Biotechnology: Pharmaceutical Preparations
  • Sector
  • JYD Consumer Discretionary
  • CING Health Care
  • Exchange
  • JYD Nasdaq
  • CING Nasdaq
  • Market Cap
  • JYD 18.9M
  • CING 21.6M
  • IPO Year
  • JYD 2023
  • CING 2021
  • Fundamental
  • Price
  • JYD $3.12
  • CING $3.49
  • Analyst Decision
  • JYD
  • CING Strong Buy
  • Analyst Count
  • JYD 0
  • CING 4
  • Target Price
  • JYD N/A
  • CING $33.00
  • AVG Volume (30 Days)
  • JYD 97.5K
  • CING 203.4K
  • Earning Date
  • JYD 12-04-2025
  • CING 11-13-2025
  • Dividend Yield
  • JYD N/A
  • CING N/A
  • EPS Growth
  • JYD N/A
  • CING N/A
  • EPS
  • JYD N/A
  • CING N/A
  • Revenue
  • JYD $80,305,742.00
  • CING N/A
  • Revenue This Year
  • JYD N/A
  • CING N/A
  • Revenue Next Year
  • JYD N/A
  • CING N/A
  • P/E Ratio
  • JYD N/A
  • CING N/A
  • Revenue Growth
  • JYD N/A
  • CING N/A
  • 52 Week Low
  • JYD $2.97
  • CING $3.22
  • 52 Week High
  • JYD $400.00
  • CING $6.01
  • Technical
  • Relative Strength Index (RSI)
  • JYD 43.67
  • CING 43.47
  • Support Level
  • JYD $3.80
  • CING $3.22
  • Resistance Level
  • JYD $3.58
  • CING $3.81
  • Average True Range (ATR)
  • JYD 0.38
  • CING 0.22
  • MACD
  • JYD -0.32
  • CING -0.02
  • Stochastic Oscillator
  • JYD 6.81
  • CING 42.34

About JYD Jayud Global Logistics Limited

Jayud Global Logistics Ltd is an end-to-end supply chain solution provider in China, with a focus on providing cross-border logistics services. The company offers freight forwarding services, supply chain management, and other value-added services.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: